Insider Transactions Reported by 10 Insiders of BriaCell Therapeutics Corp.

Symbol
BCTX, BCTXL, BCTXW, BCTXZ on Nasdaq
Location
West Vancouver, British Columbia, Canada

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

BriaCell Therapeutics Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Marc Lustig Director, 10%+ Owner $5,632,601 14 May 2024
Jamieson Bondarenko Chairman, Director $777,940 28 Dec 2022
William V. Williams President, CEO, Director $57,816 23 Dec 2022
Vaughn C. Embro-Pantalony Director $43,620 01 Aug 2022
Gadi Levin CFO & Secretary $12,870 01 Aug 2022
Martin E. Schmieg Director $2,634 01 Aug 2022
M.D. Rebecca Taub Director 01 Aug 2022
Giuseppe Del Priore Chief Medical Officer 01 Aug 2022
Jane A. Gross Director 01 Aug 2022
Miguel A. Lopez-Lago Chief Scientific Officer 01 Aug 2022

Recent Insider Transactions by Companies or Individuals for BriaCell Therapeutics Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.